It is time to re-imagine the clinical encounter at which therapies are selected, into one that is capable of identifying therapies with maximal benefit and minimal harm for individual patients. Our mission is to re-engineer clinical practice to make Personalized Trials accessible and feasible so that precision therapeutics can become widely available.